How Life Settlement Investors Make Money

The Core Return Equation

Strip away the actuarial machinery and a life settlement investment is a simple cash flow structure: money out now and along the way, one large payment in at an unknown future date.

• Cash out at purchase: the price paid to the policy owner, plus transaction costs (broker compensation, underwriting, escrow, legal).
• Cash out over time: premiums paid every year to keep the policy in force. Miss a premium beyond the 30-31 day grace period and the asset can lapse to zero.
• Cash in at maturity: the death benefit, paid by the insurance carrier when the insured passes away.

Profit equals death benefit minus purchase price minus cumulative premiums minus costs. The rate of return, though, depends entirely on timing. A $1,000,000 policy bought for $200,000 with $30,000 annual premiums produces a very different annualized return if it matures in year four (roughly $680,000 profit over a short horizon) than in year twelve (roughly $440,000 profit spread over a long one — a far lower IRR).

This is why every element of the investment process orbits one question: how long will the insured live? Buyers translate that question into a price using discounted cash flow models, which we cover in life settlement pricing mechanics, and it is why the transaction begins with medical underwriting rather than financial negotiation. The seller’s offer and the investor’s expected return are two views of the same spreadsheet.

Why Anyone Sells at a Price That Lets Investors Profit

A natural first reaction: if the investor expects to profit, isn’t the seller losing? Not necessarily — the transaction can be rational for both sides because they value the same policy differently.

The policyholder who no longer wants or can afford a policy has limited alternatives. Letting it lapse yields nothing. Surrendering a universal life policy yields only its cash surrender value, which is often small relative to face value. A life settlement typically pays 4-8 times the cash surrender value, which is why the option exists at all — the comparison is laid out in life settlement vs. surrender.

The investor, by contrast, values the policy as a long-term actuarial asset. They have the capital to pay premiums for a decade, the diversification to absorb timing risk across hundreds of policies, and the modeling to price it. The policy is worth more in their hands than in the hands of someone who was about to lapse it — and the settlement price splits that value difference.

The legal foundation for this exchange is Grigsby v. Russell (1911), where the Supreme Court recognized a policy as transferable personal property precisely because the right to sell makes the asset more valuable to its owner. The honest caveat: the split of value between seller and investor depends on competition. A seller who obtains one bid captures less of the surplus than one whose policy is auctioned to multiple funds — a dynamic explored in how life settlement value is calculated.

Life Expectancy: The Variable That Drives Everything

An investor’s realized return is a function of one dominant variable: actual survival versus the life expectancy (LE) estimate used at purchase. Buyers order independent life expectancy reports — customarily two, from separate specialized underwriting firms, taking about 2-6 weeks — that convert the insured’s medical records into a survival curve and a median life expectancy figure.

The purchase price is calibrated to that curve. If the pool of insureds matures in line with the estimates, the fund earns roughly its target return. Deviations cut both ways:

• Shorter than expected: fewer premium payments, earlier death benefit, higher IRR. (Individually unpredictable; statistically it happens to part of any pool.)
• Longer than expected: more premium outflow, delayed inflow, lower IRR — potentially negative if survival extends far enough that cumulative premiums erode the profit.

The industry learned this lesson painfully. In the late 2000s, major LE underwriters lengthened their methodologies, and portfolios priced on the older, shorter estimates saw returns fall sharply — an episode documented in the GAO’s 2010 examination of the market. Modern funds respond by using multiple LE reports, blending or taking the more conservative estimate, stress-testing survival scenarios, and updating mortality tables as medical science extends lifespans. For sellers, the takeaway is symmetrical: the LE report that sets the investor’s return also sets your offer, which is why the process described in life expectancy assessments in life settlements deserves attention rather than annoyance.

Portfolio Construction: Why Investors Buy in Bulk

A single life settlement is a bad investment for almost anyone — not because the expected value is poor, but because the variance is enormous. One insured may live five years past their median estimate; nothing about a single life is predictable. The asset only works statistically, which is why the buy side is institutional.

Fund managers construct portfolios the way an insurer builds a book:

• Scale. Hundreds to thousands of policies, so the law of large numbers pulls aggregate mortality toward the modeled curve.
• Diversification across impairments. Concentrating in one condition (say, cardiac) exposes the pool to a single medical breakthrough extending those lives. Funds spread exposure across conditions, ages, and geographies.
• Diversification across carriers. The death benefit is a claim on an insurance company, so funds cap exposure to any single carrier and favor highly rated insurers.
• Premium reserves. A dedicated reserve ensures premiums are paid even during periods with few maturities — running out of premium liquidity is one of the classic ways life settlement funds have failed.
• Duration laddering. Mixing shorter and longer LE policies smooths cash flow so the fund can meet redemptions and expenses.

This portfolio logic explains institutional appetite described in who buys life insurance policies: pension funds, asset managers, and ILS managers are precisely the investors equipped to hold large, illiquid, actuarially driven pools for a decade or more.

Scenario (illustrative $1M policy, $200k purchase, $30k/yr premiums)	Years Held	Total Invested	Gross Profit	Effect on Annualized Return
Insured passes earlier than LE estimate	4	$320,000	$680,000	Very high IRR — few premiums, early inflow
Insured matches median LE estimate	7	$410,000	$590,000	Approximately the fund’s target return
Insured outlives estimate moderately	10	$500,000	$500,000	Materially reduced IRR — time and premiums erode profit
Insured outlives estimate substantially	14	$620,000	$380,000	Low single-digit IRR; approaching breakeven territory
Policy lapses from missed premium	—	All invested capital	Total loss	Operational failure — why servicing discipline is critical

The Non-Correlation Premium

Part of how investors “make money” in life settlements is not cash flow at all — it is the portfolio value of returns that ignore financial markets. Mortality does not care about the S&P 500. A pool of policies matures on its actuarial schedule through recessions, rate shocks, and bull markets alike, making life settlement returns non-correlated with equities and most fixed income.

For institutional allocators, that non-correlation is worth paying for. An asset that delivers a similar expected return to corporate credit but moves independently of it improves the whole portfolio’s risk-adjusted profile. This is the same logic that draws capital to catastrophe bonds and other insurance-linked strategies, and it is why ILS managers have expanded from natural catastrophe risk into longevity risk.

Two nuances keep the claim honest:

• Non-correlated is not risk-free. The risks are just different — longevity extension, premium escalation, carrier credit, liquidity. A fund can lose money in a roaring bull market if its pool outlives its estimates.
• The financing channel reintroduces some market sensitivity. Funds that use leverage, or investors comparing life settlement yields to bond yields, transmit interest rate conditions into pricing — the mechanism detailed in how interest rates affect the life settlement market.

Still, over full cycles, the diversification benefit is the strategic reason this asset class exists — and the demand it creates is ultimately what funds the offers made to policy sellers.

Where Investors Lose Money: The Risk Ledger

An honest account of investor economics has to include the ways the trade goes wrong, because every risk on the investor’s ledger is priced into — that is, subtracted from — the seller’s offer.

• Longevity extension risk. The dominant risk. If insureds live meaningfully longer than the LE reports projected, premiums accumulate and the IRR decays year by year. Industry-wide LE methodology revisions have impaired whole vintages of portfolios.
• Premium escalation. Universal life cost-of-insurance rates can rise; several carriers imposed COI increases on in-force blocks, directly raising the carrying cost of settled policies.
• Carrier credit risk. The death benefit is only as good as the insurer’s ability to pay decades from now, moderated by state guaranty mechanisms with limits.
• Contestability and insurable interest risk. A policy tainted by misrepresentation or stranger-origination can be challenged. Buyers screen hard for STOLI, and the 2+ year in-force requirement in most statutes helps.
• Liquidity risk. There is no daily market. A fund needing to sell resorts to the tertiary market, often at a discount, and funds mismatching illiquid assets with redeemable share classes have collapsed.
• Operational risk. A missed premium past the 30-31 day grace period can lapse a policy worth millions — servicing discipline is existential.

Regulatory guardrails from the NAIC framework mitigate the consumer-facing failure modes, but the investment risks above are why buyers demand double-digit discount rates rather than treating policies as bonds.

Fund Structures, Fees, and the Tertiary Market

Institutional investors rarely hold raw policies on their own books; they access returns through structures, each with its own economics.

• Closed-end funds. The dominant model: capital locked for a multi-year term matched to the pool’s expected maturity profile, with management fees and performance carry resembling private equity terms.
• Open-end funds with gates. Offer periodic liquidity but must hold reserves and can suspend redemptions — the structure whose mismatch caused several high-profile failures.
• Separately managed accounts. Large pensions or insurers mandate a manager to build a bespoke pool, controlling guidelines and fees.
• Securitizations and longevity structures. Less common, packaging policy cash flows into tranched notes for ILS-style investors.

Layered on top is the tertiary market — institutions trading existing policies and whole portfolios among themselves. Tertiary trading lets an early investor realize gains before maturities arrive, lets new entrants buy seasoned pools with updated LE data, and provides the price discovery that feeds back into secondary-market bids for consumers’ policies. A liquid tertiary market makes funds more willing to bid aggressively for new policies, which supports seller pricing — one of several structural links described in the secondary market for life insurance.

Fees matter to the chain, too: management and servicing costs sit between gross portfolio returns and investor net returns, tightening the price a fund can rationally pay at acquisition.

What Investor Economics Mean for a Policy Seller

Everything above compresses into a few practical lessons for the person actually considering a sale.

• Your offer is the investor’s model output. The bid equals projected death benefit minus projected premiums, discounted at the fund’s required return. You can’t negotiate the mortality tables, but you can influence the inputs: complete medical records prevent conservative assumptions, and accurate premium illustrations prevent overstated carrying costs.
• Competition moves the discount rate. When several funds bid, the winner is typically the one accepting the lowest return — which is the highest price. This is the strongest argument for a shopped, multi-bid process over a single direct offer, and it’s the economics behind the broker vs. provider distinction.
• Expect the range, not the dream. Typical outcomes run 10-35% of face value and 4-8x cash surrender value over a 60-120 day process. Offers far outside that range warrant scrutiny in both directions.
• Net of tax is the real number. Proceeds follow the three-tier treatment of IRS Rev. Rul. 2009-13, as modified by the 2017 Tax Cuts and Jobs Act — basis recovery, ordinary income up to policy gain, capital gain beyond — detailed by the IRS and summarized in our tax treatment guide.

Investor profit and fair seller treatment are not opposites. The market works when both sides understand the same math — and the seller’s protection is process: licensed counterparties, multiple bids, and time to compare alternatives.

---

Frequently Asked Questions

How exactly does an investor profit from buying someone’s life insurance policy?

The investor pays the policy owner a lump sum — typically 10-35% of the face value — then takes over premium payments and becomes the beneficiary. When the insured passes away, the insurance carrier pays the investor the full death benefit. Profit is the death benefit minus the purchase price, all premiums paid, and transaction costs. Because the timing of the death benefit is unknown, the annualized return depends heavily on how long the insured actually lives relative to the life expectancy estimates used to set the purchase price.

What rate of return do life settlement investors target?

Institutional buyers price policies using discounted cash flow models with required returns that are typically in the low-to-mid double digits, reflecting the asset’s illiquidity, longevity uncertainty, and servicing burden. Realized returns vary widely around targets because mortality timing is uncertain: pools that mature faster than the life expectancy estimates outperform, while pools that outlive estimates underperform. Historical episodes in which life expectancy methodologies were lengthened showed how quickly projected double-digit returns can compress when survival assumptions change.

Do life settlement investors lose money if the insured lives a long time?

They can. Longevity extension is the dominant risk in the asset class. Every additional year of survival means another year of premium payments out and a further-delayed death benefit in, which mechanically lowers the internal rate of return. If survival extends far enough, cumulative premiums can consume most or all of the expected profit. Funds manage this with diversified pools, conservative life expectancy assumptions, stress testing, and premium reserves — but the risk cannot be eliminated, which is one reason buyers demand meaningful discounts at purchase.

Why are life settlement returns considered non-correlated with the stock market?

Because the return driver is mortality experience, not economic activity. A portfolio of policies pays out based on when insureds pass away, which is unaffected by equity prices, corporate earnings, or credit spreads. That independence makes the asset attractive to pension funds and ILS managers seeking diversification. The caveat is that market conditions still touch the asset indirectly: interest rates influence buyers’ required returns and financing costs, and a fund’s own liquidity structure can force sales in stressed markets. The underlying cash flows, however, remain actuarial.

If investors make money on my policy, does that mean I’m being underpaid?

Not inherently. The investor and the seller value the policy differently: the seller’s realistic alternatives are often lapse (zero) or surrender (cash value only), while the investor can hold the policy to maturity with institutional capital. A settlement typically pays 4-8 times cash surrender value, capturing part of the value difference for the seller. Whether you capture a fair share depends mostly on competition — a policy shopped to multiple licensed buyers through an auction process generally prices higher than one sold to the first bidder.

What happens to my policy after an investor buys it?

Ownership and beneficiary designation transfer to the purchasing entity, which then pays all future premiums. A servicing company administers the policy: paying premiums before the 30-31 day grace period expires, periodically verifying the insured’s status within limits set by state law, and filing the death benefit claim at maturity. The policy may also be resold in the tertiary market to another institution, but the insured’s obligations do not change — the seller has no further premium responsibility and no remaining interest in the death benefit.

How do life settlement funds handle the risk of insurance companies not paying?

Carrier credit risk is managed at the portfolio level. Funds concentrate purchases on policies issued by highly rated carriers, cap exposure to any single insurer, and monitor ratings over time. State guaranty associations provide a backstop for policyholder claims up to statutory limits if a carrier fails, though those limits are often below the face amounts of settled policies. Because the death benefit may not be claimed for a decade or more, long-horizon carrier strength is a genuine underwriting input, not an afterthought.

Can ordinary individuals invest in life settlements?

Access is largely restricted to institutional and accredited investors through funds, separately managed accounts, and ILS structures, and several regulators treat interests in life settlements as securities. The retail fractional-ownership model of the 1990s viatical era produced fraud and enforcement actions and has largely disappeared. Individuals evaluating any life settlement investment offer should verify securities registration or exemption status and understand that the asset is illiquid, long-duration, and dependent on actuarial assumptions that professional buyers spend significant resources validating.

Related Reading

• Who Buys Life Insurance Policies
• Life Settlement Pricing Mechanics
• Discount Rates Life Settlement Pricing
• Longevity Risk Life Settlement Market
• Life Settlement Tax Treatment Guide

---

Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.